Sign in
8-K

Current Report

Taysha Gene Therapies, Inc. Filed Acc 0001193125-22-177619

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d362597d8k.htm…